Mylan is proud to have one of the biggest and best portfolios in the pharmaceutical industry. We make more than 1,100 separate products and we have six industrial sites located in Europe.

Today, nearly 40% of HIV/AIDS patients receiving treatment in the developing world, depend on a Mylan ARV product.

Mylan is at the forefront of generic drug production, with the capacity to manufacture more than 54 billion doses/year, each to the highest specifications and standards. This massive global scale allows us to keep our costs low.

At Mylan, we make reliability and service excellence a habit. That's why you can confidently choose Mylan.